Zoetis Inc.’s Stock Price Soars to $153.02, Marking a Robust 2.17% Uptick in Market Performance

Zoetis Inc. (ZTS)

153.02 USD +3.25 (+2.17%) Volume: 4.97M

Zoetis Inc.’s stock price stands at 153.02 USD, showcasing an impressive intraday gain of +2.17% with a trading volume of 4.97M. Despite a year-to-date dip of -22.47%, ZTS continues to demonstrate resilience in the stock market.

Latest developments on Zoetis Inc.

Zoetis (NYSE:ZTS), a major player in animal health, experienced significant stock price movements today, following multiple events. The company assured veterinarians about the safety of its OA drugs, despite reports suggesting potential harm to pets. This news was accompanied by organizational changes, with Heidi C. Chen’s departure and Roxanne Lagano stepping in. Meanwhile, legal firms are encouraging Zoetis investors to inquire about potential losses, triggering an investigation into shareholder claims against the company. Despite these challenges, Zoetis shares are trading higher, with Piper Sandler reaffirming an “Overweight” rating and the company receiving a consensus recommendation of “Buy” from brokerages.

A look at Zoetis Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking at the Smartkarma Smart Scores for Zoetis, the company seems to have a positive long-term outlook. With a growth score of 4, it indicates that Zoetis is expected to see significant growth in the future. Additionally, the momentum score of 3 suggests that the company is gaining traction and moving in the right direction. While the value and resilience scores are not as high, Zoetis still maintains a decent dividend score of 3, providing some income for investors.

Zoetis Inc. is a company that focuses on animal health medicines and vaccines for both livestock and companion animals. Operating in various regions around the world, including North America, Europe, Africa, Asia, Australia, and Latin America, Zoetis has established a strong presence in the market. With positive scores in growth and momentum, the company appears to be on a path towards continued success and expansion in the animal health industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma